The long-type isomer of cytidine deaminase (CDD) in these bacteria can modify the chemical structure of the chemotherapy drug gemcitabine, rendering it inactive and thereby promoting chemotherapy resistance in pancreatic cancer (Geller et al., 2017). The gene discussed is CDA; the disease is familial pancreatic carcinoma.